Reviewing the potential application of miR-21 inhibitors in oral cancer therapeutics. - K AP; Selvakumar SC; Selvaraj J; Mony U; Veeraraghavan VP; Sekar D; Govindarajan S; Raj AT; Patil S (Oral oncology, 2022)